SCHEMBL21749673

SCHEMBL21749673

O=C(Cn1cc(S(=O)(=O)N2CCCC2)ccc1=O)c1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ GAA P10253 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ TSHR P16473 2/20 0.44
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C1 Q04828 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21749680 0.90 ALDH1A1 (0.48) ALDH1A1GAAL3MBTL1TSHRAKR1C3
SCHEMBL21749674 0.88 L3MBTL1 (0.46) ALDH1A1GAAL3MBTL1KMT2AHTT
SCHEMBL18038979 0.87 L3MBTL1 (0.52) ALDH1A1GAAL3MBTL1TSHRAKR1C3
SCHEMBL18038951 0.87 L3MBTL1 (0.52) ALDH1A1GAAL3MBTL1TSHRAKR1C3
SCHEMBL18038965 0.87 L3MBTL1 (0.52) ALDH1A1GAAL3MBTL1AKR1C3AKR1C1
SCHEMBL18038959 0.86 L3MBTL1 (0.56) ALDH1A1GAAL3MBTL1CYP1A2CYP2D6
SCHEMBL18038954 0.86 L3MBTL1 (0.56) ALDH1A1GAAL3MBTL1CYP1A2CYP2D6
SCHEMBL18038989 0.86 L3MBTL1 (0.56) ALDH1A1GAAL3MBTL1CYP1A2CYP2D6
SCHEMBL18038943 0.85 L3MBTL1 (0.53) ALDH1A1GAAL3MBTL1TSHRAKR1C3
SCHEMBL18038953 0.85 L3MBTL1 (0.53) ALDH1A1GAAL3MBTL1AKR1C3AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11311523-B2 Pyridinone compound and use thereof KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2022-04-26 — — US disclosed
US-20200061039-A1 PYRIDINONE COMPOUND AND USE THEREOF KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061039-A1 PYRIDINONE COMPOUND AND USE THEREOF DOCK5, DOCK2, CIB1 ALDH1A1 49/4885GAA 4691/4885L3MBTL1 2940/4885
US-11311523-B2 Pyridinone compound and use thereof DOCK5, DOCK2, CIB1 ALDH1A1 49/4885GAA 4691/4885L3MBTL1 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback